ClinicalTrials.govpublic full text
A Phase 1/2A, Randomized Study of a T Follicular Helper (TFH)-Targeting Genetic Vaccine Strategy Designed to Induce Broad, Durable Immune Responses
covid-19, sars-cov-2 infection
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 432932
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.